20 Studies Show the Cancer-Fighting Potential of this Low-Cost Drug

Greed in medicine is not new but since the COVID-19 pandemic, more and more Americans are waking up to the sad reality that much of the medical establishment is more interested in the bottom line than the health outcomes of patients.

This from thegatewaypundit.com.

We the People have well learned big pharma and the medical establishment have absolutely no interest in pursuing low-cost treatments, especially when it comes to diseases such as cancer that are a cash cow for big pharma. Fortunately, we have a growing number of medical professionals who are committed to restoring faith in our healthcare system and making affordable and effective treatments available to all Americans.

Dr. William Makis, one of the most well-known critics of the failed response to the COVID-19 pandemic, has been an enthusiastic advocate for the use of Ivermectin and mebendazole in treating a wide array of cancers. Dr. Makis listed 20 studies that show the potential for Ivermectin in fighting cancer. Here are recent studies on IVERMECTIN use in certain types of cancer:

 – BLADDER CANCER– (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage

 – LUNG CANCER– (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

 – GLIOMA– (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma

 – MULTIPLE MYELOMA– (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma

 – OVARIAN CANCER– (2023 Jawad et al) – Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells

 – PROSTATE CANCER –(2022 Lu et al) – Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer

 – COLON CANCER– (2022, Alghamdi et al) – Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats

 – PANCREATIC CANCER– (2022 Lee et al) – Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells viamitochondrial dysfunction

 – MELANOMA– (2022 Zhang et al) – Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis

 – CERVICAL CANCER– (2022, Qabbus et al) – Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media

 – HEPATOCELLULAR CARCINOMA– (2022 Lu et al) – Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

 – OSTEOSARCOMA– (2022 Hu et al) – Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma

 – GASTRIC CANCER– (2021 Rabben et al) – Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer

 – LEUKEMIA– (2020, de Castro et al) – Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

 – ESOPHAGEAL SCC– (2020, Chen et al) – Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma

 – CHOLANGIOCARCINOMA– (2019 Intyuod et al) – Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro

 – BREAST CANCER STEM CELLS –(2018 Dominguez-Gomez et al) – Ivermectin as an inhibitor of cancer stem-like cells

 – CML (CHRONIC MYELOID LEUKEMIA)– (2018 Wang et al) – Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress

 – RENAL CELL CARCINOMA– (2017 Zhu et al) – Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage

 – GLIOBLASTOMA– (2016 Liu et al) – Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress

Dr. Makis makes it clear he believes Ivermectin could be a valuable tool in the battle against cancer and explains why the medical establishment is in no hurry to explore Ivermectin’s potential:

IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines, estimated to cost 400,000 GBP per treatment. Ivermectin studies on mice include: Breast cancer, Colon cancer, glioblastoma, glioma and leukemia. I have not seen IVERMECTIN studies on Lymphoma, Testicular Cancer, Sarcomas. IVERMECTIN acts on Cancer mainly by inhibiting signaling pathways involved in cancer proliferation (Akt, Wnt, mTOR) and by inhibiting CANCER STEM CELLS.

Dr. Makis is the only trusted medical professional talking about the potential of Ivermectin. According to the McCullough Foundationa new study confirms the early returns on Ivermectin are positive:

The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research…Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.

Indeed, ivermectin in concert with mebendazole has shown even more promise in treating a wide variety of cancers.

Mebendazole, an anti-parasitic like ivermectin, has been prescribed for 100 years to help eradicate parasites—which over 60 million Americans have inside their body today, according to the CDC.

The following is for all the visual learners out there. Fascinating!

WATCH:

FURTHER: